(Q37738162)

22 August 2017

1 reference

title

When are type 1 diabetic patients at risk for cardiovascular disease? (English)

1 reference

22 August 2017

1 reference

1

Trevor J Orchard

1 reference

22 August 2017

Tina Costacou

2

1 reference

22 August 2017

1 February 2010

1 reference

22 August 2017

Current diabetes report

1 reference

22 August 2017

10

1 reference

22 August 2017

48-54

1 reference

22 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-009-0089-3

22 August 2017

0 references

cites work

Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

1 reference

12 December 2020

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

1 reference

12 December 2020

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype

1 reference

12 December 2020

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

1 reference

12 December 2020

Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes

1 reference

12 December 2020

Effects of a diet higher in carbohydrate/lower in fat versus lower in carbohydrate/higher in monounsaturated fat on postmeal triglyceride concentrations and other cardiovascular risk factors in type 1 diabetes

1 reference

12 December 2020

Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease

1 reference

12 December 2020

Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction

1 reference

12 December 2020

Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

1 reference

12 December 2020

Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus

1 reference

12 December 2020

Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction

1 reference

12 December 2020

Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes

1 reference

12 December 2020

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial

1 reference

12 December 2020

Aspirin for prevention of cardiovascular events

1 reference

12 December 2020

Adults with type 1 diabetes eat a high-fat atherogenic diet that is associated with coronary artery calcium.

1 reference

12 December 2020

Impaired stroke volume and aerobic capacity in female adolescents with type 1 and type 2 diabetes mellitus

1 reference

12 December 2020

Deficiencies of cardiovascular risk prediction models for type 1 diabetes

1 reference

12 December 2020

Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).

1 reference

12 December 2020

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

12 December 2020

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

12 December 2020

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

1 reference

12 December 2020

Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.

1 reference

12 December 2020

A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes

1 reference

12 December 2020

Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease

1 reference

12 December 2020

Metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes

1 reference

12 December 2020

Type 1 diabetes and coronary artery disease

1 reference

12 December 2020

Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.

1 reference

12 December 2020

Increased methionine sulfoxide content of apoA-I in type 1 diabetes

1 reference

12 December 2020

The Effect of Vitamin E Supplementation on Cardiovascular Risk in Diabetic Individuals With Different Haptoglobin Phenotypes

1 reference

12 December 2020

Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation

1 reference

12 December 2020

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

1 reference

12 December 2020

The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes

1 reference

12 December 2020

Early autonomic dysfunction in type 1 diabetes: a reversible disorder?

1 reference

12 December 2020

Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study

1 reference

12 December 2020

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

1 reference

12 December 2020

Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes

1 reference

12 December 2020

Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes

1 reference

12 December 2020

Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering

1 reference

12 December 2020

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

12 December 2020

Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.

1 reference

12 December 2020

Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility

1 reference

12 December 2020

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience

1 reference

12 December 2020

Haptoglobin phenotype and diabetic nephropathy

1 reference

12 December 2020

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospectiv

1 reference

12 December 2020

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy

1 reference

12 December 2020

Retinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes

1 reference

12 December 2020

Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes

1 reference

12 December 2020

The metabolic syndrome in type 1 diabetes: does it exist and does it matter?

1 reference

12 December 2020

Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo

1 reference

12 December 2020

Biological and clinical significance of haptoglobin polymorphism in humans

1 reference

12 December 2020

In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease

1 reference

12 December 2020

10.1007/S11892-009-0089-3

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20425067